Progensa PCA3 test for prostate cancer detection (Q34692442)

4 August 2017

1 reference

title

Progensa PCA3 test for prostate cancer detection (English)

1 reference

4 August 2017

1 reference

Alexandre de la Taille

series ordinal

object named as

Alexandre de la Taille

1 reference

4 August 2017

publication date

1 September 2007

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

4 August 2017

published in

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

491-497

1 reference

Cancer incidence and mortality in Europe, 2004

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Molecular PCA3 diagnostics on prostatic fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Performance of the gen-probe transcription-mediated [corrected] amplification research assay compared to that of a multitarget real-time PCR for Mycoplasma genitalium detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Age-specific reference ranges for serum prostate-specific antigen in black men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

EPCA-2: a highly specific serum marker for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Molecular markers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.491

21 January 2018

Identifiers

DOI

10.1586/14737159.7.5.491

1 reference

4 August 2017

1 reference